Finally, we showed that both miR-101 and VEGF-C interference independently enhanced cisplatin cytotoxicity in bladder cancer cells, and VEGF-C also rescued miR-101’s effect on bladder cancer cell sensitivity to cisplatin. This evidence concerns the gene VEGFC and urinary bladder cancer.